TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Pterostilbene, Vorinostat
Phytochemical Name Pterostilbene (PubChem CID: 5281727 )
Anticancer drug Name Vorinostat (PubChem CID: 5311 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 803
Pair Name Pterostilbene, Vorinostat
Disease Info [ICD-11: 2C82] Prostate cancer Investigative
Gene Regulation Down-regulation Expression HIF1A hsa3091
Down-regulation Expression IL1B hsa3553
Down-regulation Expression MTA1 hsa9112
Down-regulation Expression VEGFA hsa7422
In Vitro Model LNCaP Prostate carcinoma Homo sapiens (Human) CVCL_0395
In Vivo Model Female C57BL/6J mouse homozygous with "floxed" allele of Pten gene were used in this study.
Result Our study provides preclinical evidence that Pter/SAHA combination treatment inhibits MTA1/HIF-1α tumor-promoting signaling in PCa. The beneficial outcome of combinatorial strategy using a natural agent and an approved drug for higher efficacy and less toxicity supports further development of MTA1-targeted therapies in PCa.
03. Reference
No. Title Href
1 Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression. Cancer Med. 2017 Nov;6(11):2673-2685. doi: 10.1002/cam4.1209. Click
It has been 26275 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP